A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein ; volume:12 ; number:1 ; day:12 ; month:1 ; year:2021 ; pages:1-10 ; date:12.2021
Nature Communications ; 12, Heft 1 (12.1.2021), 1-10, 12.2021
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Kim, Cheolmin
Ryu, Dong-Kyun
Lee, Jihun
Kim, Young-Il
Seo, Ji-Min
Kim, Yeon-Gil
Jeong, Jae-Hee
Kim, Minsoo
Kim, Jong-In
Kim, Pankyeom
Bae, Jin Soo
Shim, Eun Yeong
Lee, Min Seob
Kim, Man Su
Noh, Hanmi
Park, Geun-Soo
Park, Jae Sang
Son, Dain
An, Yongjin
Lee, Jeong No
Kwon, Ki-Sung
Lee, Joo-Yeon
Lee, Hansaem
Yang, Jeong-Sun
Kim, Kyung-Chang
Kim, Sung Soon
Woo, Hye-Min
Kim, Jun-Won
Park, Man-Seong
Yu, Kwang-Min
Kim, Se-Mi
Kim, Eun-Ha
Park, Su-Jin
Jeong, Seong Tae
Yu, Chi Ho
Song, Youngjo
Gu, Se Hun
Oh, Hanseul
Koo, Bon-Sang
Hong, Jung Joo
Ryu, Choong-Min
Park, Wan Beom
Oh, Myoung-don
Choi, Young Ki
Lee, Soo-Young
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20602-5
- URN
-
urn:nbn:de:101:1-2021020718101063713731
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Cheolmin
- Ryu, Dong-Kyun
- Lee, Jihun
- Kim, Young-Il
- Seo, Ji-Min
- Kim, Yeon-Gil
- Jeong, Jae-Hee
- Kim, Minsoo
- Kim, Jong-In
- Kim, Pankyeom
- Bae, Jin Soo
- Shim, Eun Yeong
- Lee, Min Seob
- Kim, Man Su
- Noh, Hanmi
- Park, Geun-Soo
- Park, Jae Sang
- Son, Dain
- An, Yongjin
- Lee, Jeong No
- Kwon, Ki-Sung
- Lee, Joo-Yeon
- Lee, Hansaem
- Yang, Jeong-Sun
- Kim, Kyung-Chang
- Kim, Sung Soon
- Woo, Hye-Min
- Kim, Jun-Won
- Park, Man-Seong
- Yu, Kwang-Min
- Kim, Se-Mi
- Kim, Eun-Ha
- Park, Su-Jin
- Jeong, Seong Tae
- Yu, Chi Ho
- Song, Youngjo
- Gu, Se Hun
- Oh, Hanseul
- Koo, Bon-Sang
- Hong, Jung Joo
- Ryu, Choong-Min
- Park, Wan Beom
- Oh, Myoung-don
- Choi, Young Ki
- Lee, Soo-Young
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neutralizing antibody titres in SARS-CoV-2 infections
Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Neutralizing antibody titres in SARS-CoV-2 infections
Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Neutralizing antibody titres in SARS-CoV-2 infections
Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2